Allergan, Inc. (NYSE: AGN) today announced operating results for the
quarter ended March 31, 2013. Allergan also announced that its Board of
Directors has declared a first quarter ... read more
Allergan, Inc., (NYSE: AGN) today announced that Stephen J. Ryan, M.D.,
a member of the Allergan Board of Directors, died on April 29th,
2013 after a short illness. ... read more
Allergan, Inc. (NYSE: AGN) today announced that the U.S. Food and Drug
Administration (FDA) has issued a Complete Response Letter (CRL) to its
New Drug Application (NDA) for ... read more
Allergan, Inc. (NYSE: AGN) invites you to listen to David Pyott,
Chairman of the Board, President and Chief Executive Officer, and Jeff
Edwards, Executive Vice President, Finance and ... read more
Allergan, Inc. (NYSE: AGN) (“Allergan”) today announced the expiration
of the tender offer (the “Offer”) initiated by its wholly-owned
subsidiary, Groundhog Acquisition, Inc. (“Purchaser”), on January 31,
... read more
Allergan, Inc. (NYSE:AGN) and MAP Pharmaceuticals, Inc. (Nasdaq: MAPP)
today jointly announced that they have entered into a definitive merger
agreement whereby Allergan will acquire 100% of the ... read more
Allergan, Inc. (NYSE: AGN) invites you to listen to David Pyott,
Chairman of the Board, President and Chief Executive Officer, and Jeff
Edwards, Executive Vice President, Finance and ... read more